chr9-70259136-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015110.4(SMC5):āc.58C>Gā(p.Leu20Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_015110.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMC5 | NM_015110.4 | c.58C>G | p.Leu20Val | missense_variant | 1/25 | ENST00000361138.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMC5 | ENST00000361138.7 | c.58C>G | p.Leu20Val | missense_variant | 1/25 | 1 | NM_015110.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460500Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726422
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 07, 2022 | DNA sequence analysis of the SMC5 gene demonstrated a sequence change, c.58C>G, in exon 1 that results in an amino acid change, p.Leu20Val. This sequence change does not appear to have been previously described in individuals with SMC5-related disorders and has also not been described in population databases such as ExAC and gnomAD. The p.Leu20Val change affects a moderately conserved amino acid residue located in a domain of the SMC5 protein that is not known to be functional. The p.Leu20Val substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Leu20Val change remains unknown at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at